We are live on
!
Find out more
DMK
David M. Knott Portfolio holdings
AUM
$275M
1-Year Est. Return
59.23%
This Fund
S&P 500
This Quarter
Est. Return
+2.33%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$170M
AUM Growth
-$12.7M
(-7%)
Cap. Flow
-$12.5M
Cap. Flow
% of AUM
-7.34%
Top 10 Holdings %
Top 10 Hldgs %
60.5%
Holding
104
New
11
Increased
13
Reduced
10
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAPO
Vapotherm, Inc. Common Stock
VAPO
|
+$1.77M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.29M |
| 3 |
TG Therapeutics
TGTX
|
+$892K |
| 4 |
KYNB
Kyntra Bio
KYNB
|
+$849K |
| 5 |
Gilead Sciences
GILD
|
+$763K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SRCL
Stericycle Inc
SRCL
|
+$6.7M |
| 2 |
CCXI
ChemoCentryx, Inc.
CCXI
|
+$3.69M |
| 3 |
KKR & Co
KKR
|
+$2.8M |
| 4 |
Ligand Pharmaceuticals
LGND
|
+$2.73M |
| 5 |
BLU
BELLUS Health Inc.
BLU
|
+$2.47M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 41.75% |
| 2 | Financials | 15.96% |
| 3 | Industrials | 12.97% |
| 4 | Technology | 9.75% |
| 5 | Communication Services | 5.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VAPO
26
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $1.42M | 0.83% |
+6,125
| New | +$1.77M |
|
|
ALXN
27
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.37M | 0.81% |
+12,000
| New | +$1.29M |
|
28
AllianceBernstein
AB
$3.43B
| $1.37M | 0.8% |
50,500
| – | – |
|
29
BioCryst Pharmaceuticals
BCRX
$2.51B
| $1.36M | 0.8% |
397,361
| – | – |
|
|
30
TG Therapeutics
TGTX
$8.26B
| $1.36M | 0.8% |
50,773
+38,773
| +323% | +$892K |
|
31
Viking Therapeutics
VKTX
$3.75B
| $1.27M | 0.74% |
218,102
| – | – |
|
|
BRSL
32
Brightstar Lottery PLC
BRSL
$2.11B
| $1.2M | 0.7% |
107,500
| – | – |
|
|
CDTX
33
DELISTED
Cidara Therapeutics
CDTX
| $1.16M | 0.68% |
20,353
| – | – |
|
34
uniQure
QURE
$3.38B
| $1.14M | 0.67% |
31,000
+10,642
| +52% | +$436K |
|
35
Verizon
VZ
$208B
| $1.09M | 0.64% |
18,311
| – | – |
|
36
Johnson & Johnson
JNJ
$646B
| $1.08M | 0.64% |
7,280
| – | – |
|
37
Mondelez International
MDLZ
$79.6B
| $914K | 0.54% |
15,900
| – | – |
|
38
Kimberly-Clark
KMB
$36.4B
| $886K | 0.52% |
6,000
| – | – |
|
|
KYNB
39
Kyntra Bio
KYNB
$32.5M
| $811K | 0.48% |
+789
| New | +$849K |
|
|
SBBP
40
DELISTED
Strongbridge Biopharma plc.
SBBP
| $781K | 0.46% |
372,000
+75,963
| +26% | +$256K |
|
|
41
Gilead Sciences
GILD
$181B
| $695K | 0.41% |
+11,000
| New | +$763K |
|
42
DuPont de Nemours
DD
$18.5B
| $672K | 0.39% |
9,654
| – | – |
|
43
Coca-Cola
KO
$386B
| $661K | 0.39% |
13,400
| – | – |
|
44
Alkermes
ALKS
$7.95B
| $630K | 0.37% |
38,000
-20,073
| -35% | -$365K |
|
45
AT&T
T
$178B
| $628K | 0.37% |
29,194
| – | – |
|
46
Collegium Pharmaceutical
COLL
$786M
| $622K | 0.36% |
29,862
-39,189
| -57% | -$707K |
|
47
Dow Inc
DOW
$22B
| $570K | 0.33% |
12,118
| – | – |
|
|
RDUS
48
DELISTED
Radius Health, Inc.
RDUS
| $545K | 0.32% |
48,034
+5,000
| +12% | +$61.8K |
|
49
IBM
IBM
$222B
| $521K | 0.31% |
4,481
| – | – |
|
50
Canadian Natural Resources
CNQ
$101B
| $513K | 0.3% |
65,415
| – | – |
|
Similar funds
FA
KCP
HCIA
ISG
TPCM
DCM
MCL
DVC
David M. Knott's Q3 2020 Portfolio in Review
As of Q3 2020, David M. Knott held 104 positions worth $170M, down 7% from $183M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
David M. Knott withdrew a net $12.5M in Q3 2020, closing 4 positions and reducing 10 holdings. Its most notable exit was BELLUS Health Inc., an estimated $2.47M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 42% of assets, down from 45% a quarter earlier, followed by Financials and Industrials.
Against the trend, David M. Knott opened a new position in Vapotherm, Inc. Common Stock worth $1.42M.
- David M. Knott's largest Q3 2020 buy was Vapotherm, Inc. Common Stock: 6,125 shares worth $1.42M.
- David M. Knott added most to TG Therapeutics in Q3 2020, an estimated $892K increase.
- David M. Knott's biggest Q3 2020 reduction was Stericycle Inc, cutting an estimated $6.7M.
- David M. Knott fully exited BELLUS Health Inc. in Q3 2020, selling an estimated $2.47M.
- David M. Knott's ten largest holdings make up 61% of its $170M portfolio in Q3 2020.
- David M. Knott opened 11 new positions and closed 4 in Q3 2020.
- David M. Knott's portfolio value fell 7% quarter-over-quarter to $170M.
Based on David M. Knott's 13F filing for Q3 2020, filed 13 Nov 2020.